“The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats”. Alcohol and Alcoholism42 (1): 11–8. (2006). doi:10.1093/alcalc/agl085. PMID17098748.
“Antinociceptive effects of glycine transporter inhibitors in neuropathic pain models in mice”. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica130 (6): 458–63. (December 2007). doi:10.1254/fpj.130.458. PMID18079595.
“The glycine reuptake inhibitor org 25935 interacts with basal and ethanol-induced dopamine release in rat nucleus accumbens”. Alcoholism: Clinical and Experimental Research33 (7): 1151–7. (July 2009). doi:10.1111/j.1530-0277.2009.00938.x. PMID19389199.
“Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test”. Brain Research1331: 105–13. (May 2010). doi:10.1016/j.brainres.2010.03.032. PMID20303337.
“Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats”. Biological Psychiatry68 (8): 704–11. (October 2010). doi:10.1016/j.biopsych.2010.05.029. PMID20655511.
“Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions”. Journal of Neurochemistry117 (3): 516–27. (May 2011). doi:10.1111/j.1471-4159.2011.07223.x. PMID21348870.
“Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission”. Psychopharmacology221 (1): 115–31. (May 2012). doi:10.1007/s00213-011-2554-3. PMID22068461.
“The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats”. Alcohol and Alcoholism42 (1): 11–8. (2006). doi:10.1093/alcalc/agl085. PMID17098748.
“Antinociceptive effects of glycine transporter inhibitors in neuropathic pain models in mice”. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica130 (6): 458–63. (December 2007). doi:10.1254/fpj.130.458. PMID18079595.
“The glycine reuptake inhibitor org 25935 interacts with basal and ethanol-induced dopamine release in rat nucleus accumbens”. Alcoholism: Clinical and Experimental Research33 (7): 1151–7. (July 2009). doi:10.1111/j.1530-0277.2009.00938.x. PMID19389199.
“Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test”. Brain Research1331: 105–13. (May 2010). doi:10.1016/j.brainres.2010.03.032. PMID20303337.
“Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats”. Biological Psychiatry68 (8): 704–11. (October 2010). doi:10.1016/j.biopsych.2010.05.029. PMID20655511.
“Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions”. Journal of Neurochemistry117 (3): 516–27. (May 2011). doi:10.1111/j.1471-4159.2011.07223.x. PMID21348870.
“Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission”. Psychopharmacology221 (1): 115–31. (May 2012). doi:10.1007/s00213-011-2554-3. PMID22068461.
